dequalinium has been researched along with tetraphenylphosphonium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elmaleh, DR; Martuza, RL; Steichen, JD; Weiss, MJ | 1 |
| McPherson, GA; Piekarska, AE; Saltis, J; Webster, L | 1 |
2 other study(ies) available for dequalinium and tetraphenylphosphonium
| Article | Year |
|---|---|
Enhanced in vitro uptake and retention of 3H-tetraphenylphosphonium by nervous system tumor cells.
Topics: Animals; Cell Line; Chlorocebus aethiops; Dequalinium; Humans; Nervous System Neoplasms; Onium Compounds; Organophosphorus Compounds; Photochemotherapy; Rats; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1991 |
KATP channel blocking actions of quaternary ions play no role in their antiproliferative action on mouse leukaemia and rat vascular smooth muscle cells in vitro.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Animals; Antineoplastic Agents; Aorta; Cell Division; Cells, Cultured; Cisplatin; Coronary Vessels; Dequalinium; In Vitro Techniques; Leukemia L1210; Mice; Muscle Contraction; Muscle, Smooth, Vascular; Onium Compounds; Organophosphorus Compounds; Potassium Channel Blockers; Rats; Rhodamine 123; Swine; Tetraphenylborate; Vasoconstrictor Agents | 1998 |